HOME >> BIOLOGY >> NEWS
Anti-cancer compound could cause serious liver damage, report University of Pittsburgh scientists

EMBARGOED FOR RELEASE UNTIL 5 P.M. EST, MONDAY, MAY 1 An anti-cancer compound initially slated to enter clinical trials within months could harm a patient, according to a University of Pittsburgh report in the May issue of Nature Medicine. The Pittsburgh scientists found that the compound TNF-related apoptosis-inducing ligand (TRAIL) causes catastrophic damage to human liver cells while proving harmless to liver cells from mice and nonhuman primates used in preclinical testing.

Previous studies of TRAIL have shown that this compound only triggered cancer cell death, and this new drug was slated for use in early treatment studies for many types of cancer, including those of the central nervous system. This is the first study indicating that TRAIL also may kill normal, healthy cells. The TRAIL used in this study was synthesized by researchers at the University of Pittsburgh.

"Our findings with TRAIL indicate that results of standard preclinical tests may mislead investigators into believing that an agent is safe for use in humans," said Stephen Strom, Ph.D., associate professor of pathology at the University of Pittsburgh School of Medicine and senior author of the report. "We've shown that differences in the sensitivity of various species to the same compound can prove critical. Significant toxicity could result if TRAIL were used in human cancer therapy."

The researchers used liver cells (hepatocytes) taken from 20 different individuals and exposed them to concentrations of TRAIL used in prior pre-clinical studies. More than half of these hepatocytes died within 10 hours of exposure. The investigators also exposed cultured mouse and monkey hepatocytes to TRAIL but found that this compound did not trigger cell death, thus confirming results of earlier whole-animal studies. Human liver cancer cells proved sensitive to TRAIL, as initially reported.

TRAIL kills a cell by interrupting its normal life cycle, thereby causing it t
'"/>

Contact: Lauren Ward
wardle@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
30-Apr-2000


Page: 1 2

Related biology news :

1. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
2. Anti-cancer agent built from anti-inflammatory drug
3. NJIT chemist speaks Aug. 25 about compound derived from pine tree
4. New compound could give some types of cancer the one-two punch
5. Scientists identify compounds that mimic calorie restriction
6. Firefly compound lights up protein dance in living animals
7. New compound highly efficacious at reducing human tumour growth
8. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
9. New screening method turns up potential compound for treating anthrax
10. New, non-radioactive screen for antimalarial compounds
11. OHSU team discovers compound that lacks estrogens risks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2020)... (PRWEB) , ... June 11, 2020 , ... ... DNA services, announces a significant expansion of its forensic genealogy team. Bode’s ... and attorneys through proven forensic genealogy and DNA analysis methods. The team has ...
(Date:6/11/2020)... ... , ... Superior Controls, Inc. , an E Technologies Company and leading ... sciences industry, is pleased to announce the recent hiring of Ray Boudreau, who will ... Hampshire office. In his new role, Boudreau will use his extensive experience with ...
(Date:6/5/2020)... ... June 04, 2020 , ... “Although we are disappointed to have ... our attendees, staff, and the public. We remain committed to creating a global ... collaborate virtually,” said Julie Sutcliffe, President of WMIS. , The abstract ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... WESTMINSTER, Colo. (PRWEB) , ... ... ... providers of expert tissue data insights, today announced that the launch of ... PD-L1 results along with data about the tumor microenvironment (TME). , “Flagship’s ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic ... drug treatment. In an effort to better understand the cellular responses to COVID-19, ... imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules ...
(Date:6/28/2020)... ... 26, 2020 , ... The Security Industry Association ... opposition to the recently introduced bicameral Facial Recognition and Biometric Technology Moratorium ... use of nearly all biometric and related image analytics technologies, incorrectly labeling all ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... indoor environments, announced today that Derek Fournier has been appointed CEO and President. ... the Board, effective immediately. , “DeCurtis Corporation has been on an incredible ...
Breaking Biology Technology:
Cached News: